Evergreen Therapeutics Inc.
- Biotech or pharma, therapeutic R&D
Evergreen Therapeutics is a private, clinical-stage company focused on autoimmune, ophthalmic, and vascular diseases. We have offices and laboratories in Bethesda, U.S., and in Shenzhen and Yantai, China. We are seeking out-licensing opportunities for EG-501, a drug candidate aimed at treating cognitive impairment associated with systemic lupus erythematosus (SLE).
EG-501 is an NMDA receptor antagonist currently in a Phase II study in the U.S. An interim analysis has shown a clinically significant reduction in RBANS index scores. RBANS (Repeatable Battery for the Assessment of Neuropsychological Status) is a brief, individually administered test battery used to measure cognitive decline or improvement.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}